文献速递真菌感染

根霉特异性葡糖淀粉酶作为诊断毛霉病的新型生物标志物

Identification and Validation of Rhizopus-Specific Glucoamylase as a Novel Biomarker for Diagnosing Mucormycosis.
PubMed 文献 · J Infect Dis · 2026-01-01

本研究通过免疫蛋白质组学鉴定根霉分泌提取物中的免疫反应蛋白,发现70 kDa斑点为根霉特异性葡糖淀粉酶(RSG),并开发间接ELISA检测抗RSG IgG。在92例毛霉病患者和41例对照中,抗RSG IgG在验证队列的敏感性为76.1%(95%CI 61.2%-87.4%),特异性为100%(71.5%-100%)。RSG是有潜力的毛霉病诊断生物标志物,需前瞻性多中心验证。

要点

  • 抗RSG IgG在验证队列敏感性76.1%,特异性100%。
  • 培养阴性但镜检阳性病例中85.1%可检出抗体。
  • 混合真菌感染病例中87.5%可检出抗体。

核心结论

  • RSG是诊断毛霉病的潜在生物标志物,抗RSG IgG显示较强诊断前景,值得前瞻性多中心临床验证。

研究设计与样本

  • 两阶段系统性研究,结合抗原发现与临床验证。
  • 用6例毛霉病患者混合血清,通过免疫蛋白质组学鉴定根霉分泌提取物中的免疫反应蛋白点。
  • 采用液相色谱-串联质谱(LC-MS/MS)表征最具反应性的蛋白点。
  • 用纯化蛋白开发间接酶联免疫吸附试验,在92例毛霉病患者和41例对照(22例其他霉菌感染和19例单纯糖尿病)中评估诊断性能;参与者按1:1随机分为推导队列和验证队列。
  • 通过受试者工作特征曲线分析确定最佳截断值。

主要发现

  • 免疫蛋白质组学在粗提物中鉴定出3个免疫反应蛋白点(70、45和30 kDa)。
  • 最具反应性的70 kDa斑点经LC-MS/MS鉴定为根霉特异性葡糖淀粉酶(RSG),并用特异性抗根霉葡糖淀粉酶抗体确认。
  • 推导队列(46例毛霉病患者和11例对照)中,抗RSG免疫球蛋白G的受试者工作特征曲线下面积为0.933。
  • 验证队列中,抗RSG IgG敏感性为76.1%(95%置信区间61.2%-87.4%),特异性为100%(71.5%-100%)。
  • 该检测在85.1%的培养阴性但显微镜阳性的病例中检出抗体,在87.5%的混合真菌感染病例中检出抗体。

关键数值与推荐

  • 抗RSG IgG在验证队列的敏感性为76.1%(95%CI 61.2%-87.4%),特异性为100%(95%CI 71.5%-100%)。
  • 推导队列中抗RSG IgG的受试者工作特征曲线下面积为0.933。
  • 免疫蛋白质组学鉴定出3个免疫反应蛋白点(70、45和30 kDa),最具反应性的为70 kDa的RSG。

临床怎么用

  • 抗RSG IgG可作为毛霉病的无创血清学辅助诊断工具,尤其适用于培养阴性但镜检阳性的病例。
  • 在混合真菌感染中仍可检出抗RSG IgG,有助于鉴别诊断。
  • 目前尚需前瞻性多中心临床验证后方可用于常规临床诊断。

局限性

  • 研究为单中心设计,样本量有限(92例患者和41例对照)。
  • 抗RSG IgG在验证队列的敏感性为76.1%,存在假阴性可能。
  • 需前瞻性多中心临床验证确认其诊断价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mucormycosis is a life-threatening invasive fungal infection. Current diagnosis relies on insensitive techniques with prolonged turnaround times, underscoring the need for rapid noninvasive diagnostic tools. The current study aimed to identify the antigens of Rhizopus arrhizus that can facilitate serodiagnosis of mucormycosis and assess their diagnostic potential in patients. METHODS: This was a 2-stage systematic study combining antigen discovery and clinical validation. Using immunoproteomics, we identified immunoreactive protein spots in R. arrhizus secretory extract, using pooled serum samples from 6 patients with mucormycosis. We performed liquid chromatography-tandem mass spectrometry (LC-MS/MS) to characterize the most reactive spot. Next, we developed an indirect enzyme-linked immunosorbent assay using purified protein and evaluated its diagnostic performance in 92 patients with mucormycosis and 41 controls (22 with other mold infections and 19 with diabetes mellitus alone). Participants were randomly divided 1:1 into derivation and validation cohorts. Receiver operating characteristic curve analysis identified optimal cutoff values. RESULTS: Immunoproteomics identified 3 immunoreactive protein spots (70, 45, and 30 kDa) in crude extract. The most reactive 70-kDa spot was identified as Rhizopus-specific glucoamylase (RSG) by LC-MS/MS and confirmed with specific anti-Rhizopus glucoamylase antibody. In the derivation cohort (46 patients with mucormycosis and 11 controls), the area under the receiver operating characteristic curve for anti-RSG immunoglobulin (Ig) G was 0.933. In the validation cohort, anti-RSG IgG achieved 76.1% sensitivity (95% confidence interval, 61.2%-87.4%) and 100% specificity (71.5%-100%). The assay also detected antibodies in 85.1% of culture-negative but microscopy-positive cases and in 87.5% of mixed fungal infection cases. CONCLUSIONS: RSG is a potential biomarker for diagnosing mucormycosis. Anti-RSG IgG shows strong diagnostic promise and merits prospective multicenter clinical validation.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Choudhary H, Kaur H, Singh S, et al. Identification and Validation of Rhizopus-Specific Glucoamylase as a Novel Biomarker for Diagnosing Mucormycosis. J Infect Dis. 2026. PMID: 41779678. doi:10.1093/infdis/jiag126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。